Exelixis Inc
EXEL
ISIN null / Valor 1069927
Exelixis Inc
UMushroom community rating:
About company
Exelixis Inc. is a biotechnology company primarily engaged in the discovery, development, and commercialization of new medicines to treat cancer. Initially founded with a focus on using model systems genetics and genomics to understand gene function, the company has since honed its expertise in drug discovery. Exelixis is known for its development of small molecule therapies, with a particular emphasis on oncology. The company has established a robust pipeline of drug candidates and has successfully brought several products to market. Exelixis leverages strategic collaborations with other pharmaceutical and biotechnology companies to enhance its research and development efforts, thereby expanding its reach and impact in the field of cancer treatment.
Summarized from source with an LLMView SourceSector: TechnologyKey figures
Performance
Volatility
11443 M
Market cap (USD)
4,840,200
Daily traded volume (Shares)
34.14 / 33.69
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
